Tamburini J, Mouche S, Larrue C, Duployez N, Bidet A, Salotti A, Hirsch P, Rigolot L, Carras S, Temple M, Favale F, Flandrin-Gresta P, Le Bris Y, Alary AS, Mauvieux L, Tondeur S, Delabesse E, Delhommeau F, Sujobert P, Kosmider O

Blood Adv. 2023 11 21;:

Factor V Leiden interferes with protein S activity assay.

Panaget B, Wimmer J, Rolland D, Mauvieux L, Sattler L, Herb A

Res Pract Thromb Haemost. 2023 11;7(8):102234

Laboratory diagnosis of heparin-induced thrombocytopenia: A retrospective experience.

Herb A, Depierreux M, Wimmer J, Rolland D, Tebacher M, Lambert A, Ladhari C, Cristinar M, Delabranche X, Krummel T, Paya D, Schenck M, Mauvieux L, Sattler L

J Clin Lab Anal. 2023 04 23;:e24884

Standardisation of pathogenicity classification for somatic alterations in solid tumours and haematologic malignancies.

Koeppel F, Muller E, Harlé A, Guien C, Sujobert P, Trabelsi Grati O, Kosmider O, Miguet L, Mauvieux L, Cayre A, Salgado D, Preudhomme C, Karayan-Tapon L, Tachon G, Coulet F, Lespagnol A, Beroud C, Leroy K, Rouleau E, Soubeyran I

Eur J Cancer. 2021 Oct 23;159:1-15

CDX2 expression in the hematopoietic lineage promotes leukemogenesis via TGFβ inhibition.

Galland A, Gourain V, Habbas K, Güler Y, Martin E, Ebel C, Tavian M, Vallat L, Chenard MP, Mauvieux L, Freund JN, Duluc I, Domon-Dell C

Mol Oncol. 2021 May 6;:

Temporal multiomic modeling reveals a B-cell receptor proliferative program in chronic lymphocytic leukemia.

Schleiss C, Carapito R, Fornecker LM, Muller L, Paul N, Tahar O, Pichot A, Tavian M, Nicolae A, Miguet L, Mauvieux L, Herbrecht R, Cianferani S, Freund JN, Carapito C, Maumy-Bertrand M, Bahram S, Bertrand F, Vallat L

Leukemia. 2021 Apr 8;:

Epidemiology, clinical picture and long-term outcomes of FIP1L1-PDGFRA-positive myeloid neoplasm with eosinophilia: data from 151 patients.

Rohmer J, Couteau-Chardon A, Trichereau J, Panel K, Gesquiere C, Abdelali RB, Bidet A, Bladé JS, Cayuela JM, Cony-Makhoul P, Cottin V, Delabesse E, Ebbo M, Fain O, Flandrin P, Galicier L, Godon C, Grardel N, Guffroy A, Hamidou M, Hunault M, Lengline E, Lhomme F, Lhermitte L, Machelart I, Mauvieux L, Mohr C, Mozicconacci MJ, Naguib D, Nicolini FE, Rey J, Rousselot P, Tavitian S, Terriou L, Lefèvre G, Preudhomme C, Kahn JE, Groh M,

Am. J. Hematol.. 2020 Jul 28;:

Concomitant hemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID-19 and acute promyelocytic leukemia.

Baldacini M, Pop R, Sattler L, Mauvieux L, Bilger K, Gantzer J, Schneider F, Beaujeux R, Simand C, Herbrecht R

Br. J. Haematol.. 2020 May 5;:

First visualization of circulating neutrophil extracellular traps using cell fluorescence during human septic shock-induced disseminated intravascular coagulation.

Stiel L, Mayeur-Rousse C, Helms J, Meziani F, Mauvieux L

Thromb. Res.. 2019 Oct 22;183:153-158

A gelatinous leukemia.

Lefebvre T, Mauvieux L

Blood. 2019 Aug 29;134(9):785

Large deletions of the 5' region of IKZF1 lead to haploinsufficiency in B-cell precursor acute lymphoblastic leukaemia.

Morel G, Deau MC, Simand C, Caye-Eude A, Arfeuille C, Ittel A, Miguet L, Mauvieux L, Herbrecht R, Paillard C, Strullu M, Cavé H, Chan S, Kastner P, Heizmann B

Br. J. Haematol.. 2019 May 30;:

Multi-omics dataset to decipher the complexity of drug resistance in diffuse large B-cell lymphoma.

Fornecker LM, Muller L, Bertrand F, Paul N, Pichot A, Herbrecht R, Chenard MP, Mauvieux L, Vallat L, Bahram S, Cianférani S, Carapito R, Carapito C

Sci Rep. 2019 Jan 29;9(1):895

BCR-associated factors driving chronic lymphocytic leukemia cells proliferation ex vivo.

Schleiss C, Ilias W, Tahar O, Güler Y, Miguet L, Mayeur-Rousse C, Mauvieux L, Fornecker LM, Toussaint E, Herbrecht R, Bertrand F, Maumy-Bertrand M, Martin T, Fournel S, Georgel P, Bahram S, Vallat L

Sci Rep. 2019 Jan 24;9(1):701

Tuberculosis and atypical mycobacterial infections in ruxolitinib treated patients with primary or secondary myelofibrosis or polycythemia vera.

Lescuyer S, Ledoux MP, Gravier S, Natarajan-Amé S, Duval C, Maloisel F, Mauvieux L, Toussaint E, Fornecker LM, Herbrecht R

Int. J. Infect. Dis.. 2019 Jan 10;:

Molecular Minimal Residual Disease in Acute Myeloid Leukemia.

Mauvieux L, Miguet L, Fornecker L

N. Engl. J. Med.. 2018 Jun 21;378(25):2442-3

Triradial and quadriradial chromosomes detected in a case of B-cell prolymphocytic leukaemia.

Ittel A, Gervais C, Galoisy AC, M'Kacher R, Mauvieux L, Fornecker LM

Br. J. Haematol.. 2017 Aug;:

Evidence of Netosis in Septic Shock-Induced Disseminated Intravascular Coagulation.

Delabranche X, Stiel L, Severac F, Galoisy AC, Mauvieux L, Zobairi F, Lavigne T, Toti F, Anglès-Cano E, Meziani F, Boisramé-Helms J

Shock. 2017 Mar;47(3):313-317

Neutrophil Fluorescence: A New Indicator of Cell Activation During Septic Shock-Induced Disseminated Intravascular Coagulation.

Stiel L, Delabranche X, Galoisy AC, Severac F, Toti F, Mauvieux L, Meziani F, Boisramé-Helms J

Crit. Care Med.. 2016 Nov;44(11):e1132-e1136

Sumoylation Inhibits the Growth Suppressive Properties of Ikaros.

Apostolov A, Litim-Mecheri I, Oravecz A, Goepp M, Kirstetter P, Marchal P, Ittel A, Mauvieux L, Chan S, Kastner P

PLoS ONE. 2016 ;11(6):e0157767

Four genetic lymphoma-specific events (MYC, BCL2, BCL6 and CCND1) identified in a high grade B lymphoma case.

Ittel A, Hélias C, Wissler MP, Toussaint E, Miguet L, Chenard MP, Monier L, Gervais C, Mauvieux L

Blood Cancer J. 2015 Dec;5:e374

CD180 expression in B-cell lymphomas: A multicenter GEIL study.

Mayeur-Rousse C, Guy J, Miguet L, Bouyer S, Genevieve F, Robillard N, Solly F, Maar A, Bene MC, Mauvieux L

Cytometry B Clin Cytom. 2015 Sep 18

Cystine crystals in bone marrow aspirate.

Monier L, Mauvieux L

Blood. 2015 Sep;126(12):1515

Clinical laboratory medicine: continuous amelioration with a book of objectives and satisfaction survey.

Reix N, Agin A, Bahram S, Dali-Youcef N, Grucker D, Jaulhac B, Lepiller Q, Lessinger JM, Mauvieux L, Monier L, Schramm F, Stoll-Keller F, Vallat L, Ludes B, Candolfi E, Filisetti D

Ann Biol Clin (Paris). 2015 Apr 14.

Bilberry extract (Antho 50) selectively induces redox-sensitive caspase 3-related apoptosis in chronic lymphocytic leukemia cells by targeting the Bcl-2/Bad pathway.

Alhosin M, León-González AJ, Dandache I, Lelay A, Rashid SK, Kevers C, Pincemail J, Fornecker LM, Mauvieux L, Herbrecht R, Schini-Kerth VB

Sci Rep. 2015 Mar;5:8996

Fatal stimulation of acute myeloid leukemia blasts by pegfilgrastim.

Duval C, Boucher S, Moulin JC, Gourieux B, Mauvieux L, Leveque D, Herbrecht R

Anticancer Res. 2014 Nov;34(11):6747-8.

First description of the t(10;11)(q22;q23)/MLL-TET1 translocation in a T-cell lymphoblastic lymphoma, with subsequent lineage switch to acute myelomonocytic myeloid leukemia.

Ittel A, Jeandidier E, Helias C, Perrusson N, Humbrecht C, Lioure B, Mazurier I, Mayeur-Rousse C, Lavaux A, Thiebault S, Lerintiu F, Gervais C, Mauvieux L

Haematologica. 2013 Dec;98(12):e166-8

Cell-surface expression of the TLR homolog CD180 in circulating cells from splenic and nodal marginal zone lymphomas.

Miguet L, Lennon S, Baseggio L, Traverse-Glehen A, Berger F, Perrusson N, Chenard MP, Galoisy AC, Eischen A, Mayeur-Rousse C, Maar A, Fornecker L, Herbrecht R, Felman P, Van Dorsselaer A, Carapito C, Cianférani S, Mauvieux L

Leukemia. 2013 Aug;27(8):1748-50

A translocation t(2;8)(q12;p11) fuses FGFR1 to a novel partner gene, RANBP2/NUP358, in a myeloproliferative/myelodysplastic neoplasm.

Gervais C, Dano L, Perrusson N, Helias C, Jeandidier E, Galoisy AC, Ittel A, Herbrecht R, Bilger K, Mauvieux L

Leukemia. 2013 Apr;27(5):1186-8

Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations.

Dupuis A, Gaub MP, Legrain M, Drenou B, Mauvieux L, Lutz P, Herbrecht R, Chan S, Kastner P

Leukemia. 2013 Feb;27(2):503-7

Therapy-related acute myeloid leukemia (t-AML) with poor-risk cytogenetics in two patients with persistent molecular complete remission of acute promyelocytic leukemia.

Ojeda-Uribe M, Schneider A, Luquet I, Berceanu A, Cornillet-Lefebvre P, Jeandidier E, Lioure B, Ades L, Mauvieux L, Himberlin C

Eur J Haematol. 2012 Sep;89(3):267-72

A cytogenetic study of 397 consecutive acute myeloid leukemia cases identified three with a t(7;21) associated with 5q abnormalities and exhibiting similar clinical and biological features, suggesting a new, rare acute myeloid leukemia entity.

Jeandidier E, Gervais C, Radford-Weiss I, Zink E, Gangneux C, Eischen A, Galoisy AC, Helias C, Dano L, Cammarata O, Jung G, Harzallah I, Guerin E, Martzolff L, Drenou B, Lioure B, Tancredi C, Rimelen V, Mauvieux L

Cancer Genet. 2012 Jul-Aug;205(7-8):365-72

[Post-varicella cerebral thrombophlebitis with anti-protein S: report of a pediatric case].

Samyn B, Grunebaum L, Amiral J, Ammouche C, Lounis K, Eicher E, Mauvieux L, Desprez D

Ann Biol Clin (Paris). 2012 Jan-Feb;70(1):99-103.

[Anti-PF4 antibodies and thrombophlebitis in a child with cerebral venous thrombosis].

Desprez D, Desprez P, Tardy B, Amiral J, Droulle C, Ducassou S, Mauvieux L, Grunebaum L

Ann Biol Clin (Paris). 2010 Nov-Dec;68(6):725-8.

Proteomic analysis of malignant B-cell derived microparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis.

Miguet L, Bechade G, Fornecker L, Zink E, Felden C, Gervais C, Herbrecht R, van Dorsselaer A, Mauvieux L, Sanglier-Cianferani S

J Proteome Res. 2009 Jul;8(7):3346-54.

Stimulation of B-cell lymphoproliferations with CpG-oligonucleotide DSP30 plus IL-2 is more effective than with TPA to detect clonal abnormalities.

Struski S, Gervais C, Helias C, Herbrecht R, Audhuy B, Mauvieux L

Leukemia. 2009 Mar;23(3):617-9

ETV6/GOT1 fusion in a case of t(10;12)(q24;p13)-positive myelodysplastic syndrome.

Struski S, Mauvieux L, Gervais C, Helias C, Liu KL, Lessard M

Haematologica. 2008 Mar;93(3):467-8.

Polycythemia vera transforming to acute myeloid leukemia and complex abnormalities including 9p homogeneously staining region with amplification of MLLT3, JMJD2C, JAK2, and SMARCA2.

Helias C, Struski S, Gervais C, Leymarie V, Mauvieux L, Herbrecht R, Lessard M

Cancer Genet Cytogenet. 2008 Jan 1;180(1):51-5.

[A cytological, immunophenotypical and cytogenetical study of 136 consecutive cases of B-cell chronic lymphoid hemopathies]

Struski S, Leymarie V, Helias C, Falkenrodt A, Fohrer C, Audhuy B, Lioure B, Moskovtchenko P, Mazurier I, Galoisy AC, Gervais C, Mauvieux L, Herbrecht R, Bergerat JP, Lessard M

Pathol Biol (Paris). 2007 Feb;55(1):59-72

Clinical, cytogenetic and molecular characteristics of 14 T-ALL patients carrying the TCR beta-HOXA rearrangement: a study of the Groupe Francophone de Cytogenetique Hematologique

Cauwelier B, Cave H, Gervais C, Lessard M, Barin C, Perot C, Van den Akker J, Mugneret F, Charrin C, Pages MP, Gregoire MJ, Jonveaux P, Lafage-Pochitaloff M, Mozzicconacci MJ, Terre C, Luquet I, Cornillet-Lefebvre P, Laurence B, Plessis G, Lefebvre C, Leroux D, Antoine-Poirel H, Graux C, Mauvieux L, Heimann P, Chalas C, Clappier E, Verhasselt B, Benoit Y, Moerloose BD, Poppe B, Van Roy N, Keersmaecker KD, Cools J, Sigaux F, Soulier J, Hagemeijer A, Paepe AD, Dastugue N, Berger R, Speleman F

Leukemia. 2007 Jan;21(1):121-8

Microparticles: a new tool for plasma membrane sub-cellular proteomic.

Miguet L, Sanglier S, Schaeffer C, Potier N, Mauvieux L, Van Dorsselaer A

Subcell. Biochem.. 2007 ;43:21-34

Discovery and identification of potential biomarkers in a prospective study of chronic lymphoid malignancies using SELDI-TOF-MS.

Miguet L, Bogumil R, Decloquement P, Herbrecht R, Potier N, Mauvieux L, Van Dorsselaer A

J Proteome Res. 2006 Sep;5(9):2258-69.

Successful treatment with imatinib mesylate in a case of chronic myeloproliferative disorder with a t(5;12)(q33;p13.1) without eosinophilia.

Nadal N, Flandrin P, Cornillon J, Delabesse E, Mauvieux L, Olaru D, Morel S, Campos L

Cancer Genet Cytogenet. 2006 Sep;169(2):174-5.

Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization.

Miguet L, Pacaud K, Felden C, Hugel B, Martinez MC, Freyssinet JM, Herbrecht R, Potier N, van Dorsselaer A, Mauvieux L

Proteomics. 2006 Jan;6(1):153-71.

High incidence of Hox11L2 expression in children with T-ALL.

Mauvieux L, Leymarie V, Helias C, Perrusson N, Falkenrodt A, Lioure B, Lutz P, Lessard M

Leukemia. 2002 Dec;16(12):2417-22.